|
Initial 2 of 5.Based on the available information, this event is deemed to be a reportable malfunction.Batch record review: lot 4f00943 was manufactured 05/jun/2024, in mlk-6 line, with a total of (b)(4) market units (mkus).The complaints investigator performed a batch record review on 23/may/2025, to verify if all the applicable procedures were followed and no issues were found; all the components for assembly were correct per bill of materials (bom) and all the tooling information documented was also correct, system application product (sap) material identification (id) 1002436 and manufacturing order (b)(4).Review of the batch record showed that all relevant tests required during the manufacturing process and final product release had been fulfilled and met the requirements.No discrepancy related to this issue were found within the documentation.The reported malfunction could be generated during the manufacturing process of the final line, therefore no further batch record review of the subassembly lots was required.Photograph, video and/or physical sample evaluation: there are photographs associated with this case and in these, the reported defect can be seen.No unused return sample was expected.Historical complaints review: on 23/may/2025, complaints investigator ran a query in database in order to verify the complaints reported for the mlk-6 manufacturing line for the malfunction "skin barrier in contact with skin is too rough or sharp, sharp edges at stoma may occur" defect from 01/jan/2023 to 23/may/2025 and no additional complaints were identified.Historical nonconformance review: on 23/may/2025, complaints investigator ran a query in database looking for any in process nonconformance / corrective action / preventive actions (capa) (s) associated to the malfunction "skin barrier in contact with skin is too rough or sharp, sharp edges at stoma may occur" defect for the lot number 4f00943 and as result, no nonconformance / capa (s) for this malfunction were generated during the manufacturing process of the referenced lot.Defect rate analysis: there have only been 5 defective parts confirmed to date from a lot size of (b)(4) products.This represents a defect rate of only (b)(4), which is well within an appropriate acceptable quality level (aql) for this defect which should be (b)(4) based on our process instruction.In addition, all of the in-process testing on this lot did not find a single defective unit, which confirms that the lot is unlikely to breach an acceptable quality level (aql) of (b)(4).To date, it is well within our accepted acceptable quality level (aql) for this type of failure mode or defect.Conclusion: there are photographs associated with this case and in these, the reported defect can be seen.A review of batch records was completed and showed that all relevant tests required during the manufacturing process and final product release had been fulfilled and met the requirements.No discrepancies related to this issue were found within the documentation.No additional complaints for mlk-6 line were identified from 01/jan/2023 to 23/may/2025.This issue will be monitored through the post market product monitoring review process, standard operating procedure (sop).To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number: reporting site: 1049092, manufacturing site: 9618003.
|